SLV.WA Stock - Selvita S.A.
Unlock GoAI Insights for SLV.WA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $342.01M | $346.72M | $360.68M | $310.92M | $137.36M |
| Gross Profit | $267.82M | $275.56M | $292.62M | $251.26M | $116.36M |
| Gross Margin | 78.3% | 79.5% | 81.1% | 80.8% | 84.7% |
| Operating Income | $-487,000 | $69.31M | $39.92M | $26.08M | $19.54M |
| Net Income | $-6,098,000 | $69.88M | $30.31M | $14.90M | $18.00M |
| Net Margin | -1.8% | 20.2% | 8.4% | 4.8% | 13.1% |
| EPS | $-0.33 | $3.81 | $1.42 | $0.81 | $1.05 |
Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.
Visit WebsiteEarnings History & Surprises
SLV.WAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 18, 2025 | — | — | — | — |
Q2 2025 | May 22, 2025 | — | $-0.05 | — | — |
Q1 2025 | Mar 27, 2025 | — | $0.20 | — | — |
Q4 2024 | Nov 21, 2024 | — | $0.13 | — | — |
Q3 2024 | Sep 24, 2024 | — | $-0.55 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.12 | — | — |
Q1 2024 | Mar 28, 2024 | — | $3.48 | — | — |
Q4 2023 | Nov 15, 2023 | — | $-0.23 | — | — |
Q3 2023 | Sep 27, 2023 | — | $0.43 | — | — |
Q2 2023 | May 31, 2023 | — | $0.13 | — | — |
Q4 2022 | Dec 31, 2022 | $0.49 | $0.69 | +41.2% | ✓ BEAT |
Q4 2022 | Nov 9, 2022 | — | $0.49 | — | — |
Q3 2022 | Sep 6, 2022 | — | $0.20 | — | — |
Q2 2022 | May 31, 2022 | — | $0.27 | — | — |
Q2 2022 | Apr 1, 2022 | — | $0.44 | — | — |
Q4 2021 | Nov 24, 2021 | — | $-0.13 | — | — |
Q3 2021 | Sep 22, 2021 | — | $-0.02 | — | — |
Q2 2021 | May 26, 2021 | — | $0.51 | — | — |
Q1 2021 | Mar 30, 2021 | — | $0.26 | — | — |
Q4 2020 | Nov 24, 2020 | — | $0.24 | — | — |
Latest News
Frequently Asked Questions about SLV.WA
What is SLV.WA's current stock price?
What is the analyst price target for SLV.WA?
What sector is Selvita S.A. in?
What is SLV.WA's market cap?
Does SLV.WA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SLV.WA for comparison